IDO1 and early-onset autosomal dominant Alzheimer disease: Several of these proteins are increased in the brains of patients with Alzheimer's disease, so the similarity of this activity to the action of β-amyloid fragments has prompted the suggestion that the kynurenine pathway may be involved in the etiology of this disorder, an idea consistent with the demonstration that amyloid-β induces IDO expression (122, 123).